Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Join
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Join
FREE
What does Trump's win mean for pharma?
With Donald Trump securing a second presidential term, what issues should be top of mind for the pharmaceutical sector in the US?
Boehringer, Amgen and Novartis rank top for cardiovascular patient groups
Boehringer Ingelheim, Amgen and Novartis have been awarded the highest reputation scores by several cardiovascular patient advocacy groups.
Ipsen's Jennifer Schranz on rethinking rare disease for women
Jennifer Schranz, SVP and Global Head of Rare Diseases, Ipsen, joins the podcast to discuss the burden faced by women with rare diseases.
Boehringer pledges $5m to WHO Foundation mental health initiative
Discover how this partnership could enhance access to quality healthcare, with an emphasis on mental health services for vulnerable populations in the Americas.
Astellas’ Martina Dempsey on achieving equal footing for women in pharma
Martina Dempsey, VP of Commercial Strategy and Operations at Astellas Europe, discusses empowering women in the pharmaceutical industry.
Lundbeck to acquire Longboard and potential blockbuster epilepsy drug
Lundbeck will acquire Longboard Pharmaceuticals, aiming to strengthen its portfolio with its potential blockbuster epilepsy treatment.
Thomas J. Fuchs appointed as Lilly's first Chief AI Officer
Eli Lilly and Company appoints their first Chief AI Officer in Thomas J. Fuchs, to spearhead the strategic direction and leadership of AI.
World Mental Health Day with Boehringer Ingelheim’s Nedim Pipic
Nedim Pipic, Senior Vice President and Global Therapeutic Area Head for Mental Health, Boehringer Ingelheim marks World Mental Health Day.
Gilead expands access to PrEP HIV candidate in 120 countries
A new licensing agreement from Gilead Sciences and six generic drug manufacturers is poised to transform HIV prevention efforts
ViiV Healthcare’s Jean-Bernard Simeon on ending the HIV epidemic
Join JB, ViiV Healthcare Europe to explore the HIV landscape in Europe, the UNAIDS plan to end the epidemic by 2030 and more in this podcast.
←
1
2
3
…
5
6
7
8
9
10
11
…
20
21
22
→
We’ve noticed you’re accessing
from
North/South America.
View
View